Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification-A role in pathogenesis and antiproliferative chemotherapy

Allen, 1993, A simplified method for the purification of human red blood cell glyoxalase I. Characteristics, immunoblotting and inhibitor studies, J. Protein Chem., 12, 111, 10.1007/BF01026032

Araki, 1995, Macrophage scavenger receptor mediates endocytic uptake and degradation of advanced glycation end products of the Maillard reaction, Eur. J. Biochem., 230, 408, 10.1111/j.1432-1033.1995.0408h.x

Ayoub, 1993, Inhibition of proliferation of human leukemia 60 cells by methylglyoxal in vitro, Leuk. Res., 17, 397, 10.1016/0145-2126(93)90094-2

Brambilla, 1985, Methylglyoxal-induced DNA-protein crosslinks and cytotoxicity in Chinese hamster ovary cells, Carcinogenesis, 6, 683, 10.1093/carcin/6.5.683

Brownlee, 1986, Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking, Science, 232, 1629, 10.1126/science.3487117

Buttke, 1994, Oxidative stress as a mediator of apoptosis, Immunol. Today, 15, 7, 10.1016/0167-5699(94)90018-3

Cameron, 1992, Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats, Diabetologia, 35, 946, 10.1007/BF00401423

Cook, 1995, Kinetic characteristics of Zeneca ZD5522, a potent inhibitor of human and bovine lens aldose reductase, Biochem. Pharmacol., 49, 1043, 10.1016/0006-2952(95)98499-Y

Creighton, 1988, Optimization of efficiency in the glyoxalase pathway, Biochemistry, 27, 7376, 10.1021/bi00419a031

Diamond, 1992, Glomerular macrophages and the mesangial proliferative response in experimental nephrotic syndrome, Amer. J. Pathol., 141, 887

Dills, 1993, Nutritional and physiological consequences of tumor glycolysis, Parasitology, 107, S177, 10.1017/S0031182000075600

Espat, 1994, Tumor-necrosis-factor and cachexia-a current perspective, Surgical Oncol., 3, 255, 10.1016/0960-7404(94)90027-2

Faggin, 1985, Induction of sister-chromatid exchanges in Chinese hamster ovary cells by the biotic ketoaldehyde methlyglyoxal, Mut. Res., 144, 189, 10.1016/0165-7992(85)90138-1

Glomb, 1995, Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction, J. Biol. Chem., 276, 10017, 10.1074/jbc.270.17.10017

Grimshaw, 1992, Aldose reductase: model for a new paradigm of enzymic perfection in detoxification catalysts, Biochemistry, 31, 10139, 10.1021/bi00157a001

Haik, 1994, Methylglyoxal concentration and glyoxalase activities in the human lens, Exp. Eye Res., 59, 497, 10.1006/exer.1994.1135

Hammes, 1991, Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy, 88, 11555

Jerzykowski, 1975, Changes of certain pharmacological and biochemical indices in acute methylglyoxal poisoning, Arch. Immunol. Therap. Exp., 23, 549

Kador, 1988, The role of aldose reductase in the development of diabetic complications, Med. Res. Revs., 8, 325, 10.1002/med.2610080302

Kang, 1996, Effect of methylglyoxal on human leukaemia 60 cell growth: modification of DNA, G, growth arrest and induction of apoptosis, Leuk. Res., 10.1016/0145-2126(95)00162-X

Kasai, 1982, Mutagenicity of methylglyoxal in coffee, Gann, 73, 681

Koop, 1985, Identification of ethanol-inducible P-450 isozyme 3a as the acetone and acetol monoxygenase of rabbit microsomes, J. Biol. Chem., 260, 13607, 10.1016/S0021-9258(17)38768-9

Krymkiewicz, 1973, Reactions of methylglyoxal with nucleic acids, FEBS Lett., 29, 51, 10.1016/0014-5793(73)80013-4

Larsen, 1985, Immunological comparison of glyoxalase I from yeast and mammals with quantitative determination of the enzyme in human tissues by radioimmunoassay, Comp. Biochem. Physiol., 82B, 625

Limb, 1994, Expression of messenger-RNA coding for TNF-alpha, IL-lbeta and IL-6 by cells infiltrating retinal membranes, Graeffes Arch. Clin. Exp. Opthalmol., 232, 646, 10.1007/BF00171378

Lo, 1992, Inhibition of proliferation of human leukemia 60 cells by diethyl esters of glyoxalase inhibitors in vitro, Biochem. Pharmacol., 44, 2357, 10.1016/0006-2952(92)90680-H

Lo, 1994, Binding and modification of proteins by methylglyoxal under physiological conditions: a kinetic and mechanistic study with Nα-acetylarginine, Nα-acetylcysteine and Nα-acetyl-lysine, and bovine serum albumin, J. Biol. Chem., 269, 32299, 10.1016/S0021-9258(18)31635-1

Lo, 1994, The reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteins, Biochem. Pharmacol., 48, 1865, 10.1016/0006-2952(94)90584-3

Lovett, 1983, Stimulation of rat mesangial cell proliferation by macrophage interleukin 1, J. Immunol., 131, 2830, 10.4049/jimmunol.131.6.2830

Lubec, 1991, Influence of l-arginine on glucose-mediated collagen cross links precursors in patients with diabetes mellitus, Amino Acids, 1, 73, 10.1007/BF00808093

Lyles, 1992, The metabolism of aminoacetone to methylglyoxal by semicarbazide-sensitive amino oxidase in human umbilical artery, Biochem. Pharmacol., 43, 1409, 10.1016/0006-2952(92)90196-P

McCance, 1993, Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus, J. Clin. Invest., 91, 2470, 10.1172/JCI116482

McLellan, 1992, The assay of methylglyoxal in biological systems by derivatization with 1,2-diamino-4,5-dimethoxybenzene, Anal. Biochem., 206, 17, 10.1016/S0003-2697(05)80005-3

McLellan, 1994, The glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications, Clin. Sci., 87, 21, 10.1042/cs0870021

Menzel, 1991, Alterations of biochemical and biomechanical properties of rat tail tendons caused by non-enzymatic glycation and their inhibition by dibasic amino acids arginine and lysine, Diabetologia, 43, 12, 10.1007/BF00404018

Monnier, 1986, Relation between complications of type I diabetes mellitus and collagen-linked fluorescence, New Engl. J. Med., 314, 403, 10.1056/NEJM198602133140702

Nishimura, 1993, Quantitative determination of human aldose reductase by enzyme-linked immunosorbent assay, Biochem. Pharmacol., 46, 21, 10.1016/0006-2952(93)90343-U

Nukaya, 1990, N-2 Acetylation of 2'-deoxyguanosine by coffee mutagens, methylglyoxal and hydrogen peroxide, Mutat. Res., 245, 251, 10.1016/0165-7992(90)90154-C

Ohmori, 1989, Biosynthesis and degradation of methylglyoxal in animals, 397

Palkama, 1991, Induction of interleukin I production by ligands binding to the scavenger receptor in human monocytes and the THP-1 cell line, Immunology, 74, 432

Papoulis, 1995, Identification of N2-(1-carboxyethyl)guanine (CEG) as a guanine advanced glycosylation end-product, Biochemistry, 34, 648, 10.1021/bi00002a032

Phillips, 1993, The formation of methylglyoxal from triose phosphates, 212, 101

Phillips, 1993, Formation of methylglyoxal and D-lactate in human red blood cells in vitro, Biochem. Soc. Trans., 21, 163S, 10.1042/bst021163s

Phillips, 1993, Modification of the glyoxalase system in streptozotocin-induced diabetic rats: effect of the aldose reductase inhibitor Statil, Biochem. Pharmacol., 46, 805, 10.1016/0006-2952(93)90488-I

Pompliano, 1990, Stabilization of a reaction intermediate as a catalytic device: definition of the functional role of the flexible loop in triosephosphate isomerase, Biochemistry, 29, 3186, 10.1021/bi00465a005

Praloran, 1995, Increased levels of serum macrophage colony stimulating factor (M-CSF or CSF-1) in patients with chronic renal insufficiency (CRF): facts and hypothesis, Cytokine, 7, 221

Rae, 1990, Kinetic analysis of the human erythrocyte glyoxalase system using 1NMR and computer model, Eur. J. Biochem., 193, 83, 10.1111/j.1432-1033.1990.tb19307.x

Rahman, 1990, Formation of strand breaks and interstrand cross-links in DNA by methylglyoxal, J. Biochem. Toxicol., 5, 161, 10.1002/jbt.2570050305

Rajavashisth, 1990, Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins, Nature, 344, 254, 10.1038/344254a0

Ray, 1981, Isolation of methylglyoxal synthase from goat liver, J. Biol. Chem., 256, 6230, 10.1016/S0021-9258(19)69151-9

Reichard, 1979, Plasma acetone in fasting humans, J. Clin. Invest., 63, 619, 10.1172/JCI109344

Reichard, 1986, Acetone metabolism in humans during diabetic ketoacidosis, Diabetes, 35, 668, 10.2337/diabetes.35.6.668

Richard, 1991, Kinetic parameters for the elimination reaction catalyzed by triosephosphate isomerase and an estimation of the reaction's physiological significance, Biochemistry, 30, 4581, 10.1021/bi00232a031

Roubenoff, 1993, Humoral mediation of changing body-composition during aging and chronic inflammation, Nutrit. Revs., 51, 1, 10.1111/j.1753-4887.1993.tb03045.x

Schmidt, 1994, The endothelial cell binding site for advanced glycation endproducts consists of a complex: an integral membrane protein and a lactoferrin-like polypeptide, J. Biol. Chem., 269, 9882, 10.1016/S0021-9258(17)36965-X

Shapiro, 1969, On the reaction of guanine with glyoxal, pyruvaldehyde, and kethoxal, and the structure of the acylguanines, 8, 238

Shaw, 1994, Monitoring the progress of nonenzymatic glycation in vitro, Int. J. Peptide Protein Res., 44, 594, 10.1111/j.1399-3011.1994.tb01149.x

Shaw, 1994, Nonspecific binding of advanced-glycosylation end-products to macrophages outweighs specific receptor-mediated interactions, Biochem. J., 304, 121, 10.1042/bj3040121

Soulis-Liparota, 1991, Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozotocin-induced diabetic rat, Diabetes, 40, 1328, 10.2337/diabetes.40.10.1328

Stewart, 1995, Biologic control of the tumor-necrosis-factor and interleukin-1 signaling cascade, Amer. J. Kidney Diseases, 25, 954, 10.1016/0272-6386(95)90582-0

Takahashi, 1993, Identity of a major 3-deoxyglucosone-reducing enzyme with aldehyde reductase in rat liver established by amino acid sequencing and cDNA expression, Gene, 127, 249, 10.1016/0378-1119(93)90728-L

Taylor, 1988, The biochemistry of diabetes, Biochem. J., 250, 625, 10.1042/bj2500625

Thornalley, 1988, Modification of the glyoxalase system in human red blood cells by glucose in vitro, Biochem. J., 254, 751, 10.1042/bj2540751

Thornalley, 1993, The glyoxalase system in health and disease, Mol. Aspects of Med., 14, 287, 10.1016/0098-2997(93)90002-U

Thornalley, 1995, Advances in glyoxalase research, 20, 99

Thornalley, 1994, Anti-malarial activity of the glyoxalase I inhibitor diester, S-p-bromobenzylglutathione diethyl ester, Biochem. Pharmacol., 47, 418, 10.1016/0006-2952(94)90035-3

Thornalley, 1995, Novel antitumor agents designed from the glyoxalase system, 36, 386

Tucker, 1989, Cytogenetic response to 1,2-dicarbonyls and hydrogen peroxide in Chinese hamster ovary AUXB1 cells and human peripheral lymphocytes, Mutat. Res., 224, 269, 10.1016/0165-1218(89)90166-3

Ueno, 1991, Subchronic oral toxicity of glyoxal via drinking water in rats, Fundamental Appld. Toxicol., 16, 763, 10.1016/0272-0590(91)90162-W

Vaca, 1994, Development of a 32P-postlabelling technique for the analysis of 2'-deoxyguanosine-3'-monophosphate and DNA of methylglyoxal, Carcinogenesis, 15, 1887, 10.1093/carcin/15.9.1887

Vander Jagt, 1975, Effects of pH and thiols on the kinetics of yeast glyoxalase I. An evaluation of the random pathway mechanism, Biochemistry, 14, 3669, 10.1021/bi00687a024

Vander Jagt, 1990, D-Lactate production in erythrocytes infected with Plasmodium falciparum, Mol. Biochem. Parasitol., 42, 277, 10.1016/0166-6851(90)90171-H

Vander Jagt, 1992, Reduction of trioses by NADPH-dependent aldo-keto reductase, J. Biol. Chem., 267, 4364, 10.1016/S0021-9258(18)42844-X

Vince, 1969, Glyoxalase inhibitors as potential anticancer agents, Biochem. Biophys. Res. Comm., 35, 593, 10.1016/0006-291X(69)90445-8

Westwood, 1994, Receptor-mediated endocytic uptake of methylglyoxal-modified protein, 269, 32293

Westwood, 1995, Molecular characteristics of methylglyoxal-modified bovine and human serum albumins, 4, 359

Westwood, 1995, Cytokine synthesis and secretion induced by methylglyoxal-modified proteins, Diabetic Med., 12, 549